Pioglitazone
- Product NDC
- 51079-514
- 11-digit product format
- 510790514
- Labeler code
- 51079
- Product ID
- 51079-514_7d7c9874-0673-255a-e053-2991aa0ab6ca
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- pioglitazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mylan Institutional Inc.
- Application
- ANDA076801
- Marketing category
- ANDA
- Marketing start
- 2012-09-06
- Marketing end
- 2020-01-31
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record